Showing results (1-10 of 92) with videos related to
Sort By:
Pageof 10
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 18, 2006
[Diagnostic criteria for diabetes in older subjects]Satoshi Ugi, Atsunori KashiwagiMolecular and Cellular Biology|March 9, 2002
Protein phosphatase 2A forms a molecular complex with Shc and regulates Shc tyrosine phosphorylation and downstream mitogenic signalingSatoshi Ugi, Takeshi Imamura, William Ricketts, et al.The Journal of Biological Chemistry|November 3, 2004
Insulin-induced beta-arrestin1 Ser-412 phosphorylation is a mechanism for desensitization of ERK activation by Galphai-coupled receptorsChristopher J Hupfeld, Jamie L Resnik, Satoshi Ugi, et al.European Journal of Internal Medicine|August 19, 2007
Massive pericardial effusion secondary to Hashimoto's diseaseYasushi Omura, Satoshi Ugi, Toshiro Sugimoto, et al.The Journal of Biological Chemistry|March 19, 2002
Phosphatidylinositol 3-kinase is required for insulin-stimulated tyrosine phosphorylation of Shc in 3T3-L1 adipocytesSatoshi Ugi, Prem M Sharma, William Ricketts, et al.Journal of Diabetes Investigation|January 6, 2017
Novel subtype of congenital partial lipodystrophy with mandibular hypoplasia, sensorineural deafness and short stature of unknown genetic originHaruka Sasaki, Kumiko Ohkubo, Kunihisa Kobayashi, et al.Molecular Endocrinology (Baltimore, Md.)|October 16, 2004
Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytesPrem M Sharma, Hyun-Shik Son, Satoshi Ugi, et al.Journal of Biochemistry|July 23, 2004
Protein-tyrosine phosphatase 1B associates with insulin receptor and negatively regulates insulin signaling without receptor internalizationKun Shi, Katsuya Egawa, Hiroshi Maegawa, et al.American Journal of Physiology. Endocrinology and Metabolism|October 11, 2012
MicroRNA-494 regulates mitochondrial biogenesis in skeletal muscle through mitochondrial transcription factor A and Forkhead box j3Hirotaka Yamamoto, Katsutaro Morino, Yoshihiko Nishio, et al.Endocrine Journal|July 21, 2007
Short-term low-dosage pioglitazone treatment improves vascular dysfunction in patients with type 2 diabetesHiroshi Maegawa, Yoshihiko Nishio, Keiko Nakao, et al.Pageof 10